WO2021024135A1 - An improved process for preparation of methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate - Google Patents

An improved process for preparation of methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate Download PDF

Info

Publication number
WO2021024135A1
WO2021024135A1 PCT/IB2020/057273 IB2020057273W WO2021024135A1 WO 2021024135 A1 WO2021024135 A1 WO 2021024135A1 IB 2020057273 W IB2020057273 W IB 2020057273W WO 2021024135 A1 WO2021024135 A1 WO 2021024135A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
preparation
methyl
phenyl
Prior art date
Application number
PCT/IB2020/057273
Other languages
French (fr)
Inventor
Venkata Krishna Kishore NARKEDIMILLI
Ramesh Kumar DURGA
Balram BHAVANI
Aminul Islam
Original Assignee
Coromandel International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coromandel International Limited filed Critical Coromandel International Limited
Priority to BR112022001999A priority Critical patent/BR112022001999A2/en
Priority to MX2022001424A priority patent/MX2022001424A/en
Publication of WO2021024135A1 publication Critical patent/WO2021024135A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Definitions

  • the present invention relates to an improved process for preparing substituted cyanophenoxy-pyrimidinyloxy-phenyl acrylate derivatives.
  • the present invention specifically relates to an improved process for the preparation of methyl (2E)-2-(2- ⁇ [6-(2-cyanophenoxy)pyrimidin-4-yl]oxy ⁇ phenyl)-3- methoxyacrylate having the following Formula I.
  • Azoxystrobin is disclosed in US 5,395,837 and is a plant protection fungicide with protectant, curative, eradicant, translaminar and systemic properties. Azoxystrobin is a systemic fungicide commonly used in agriculture.
  • US 5,395,837 discloses a process for the preparation of Azoxystrobin which involves reaction between 2-cyanophenol and (E)-methyl 2-[2-(6-chlorpyridimin-4- yloxy)phenyl]-3-methoxypropenoate at temperatures ranging between 95 °C to 100 °C in dimethyl formamide in the presence of stoichiometric amounts of potassium carbonate and a catalytic amount of copper(I) chloride which is shown below :
  • US 8,471,013 B2 A1 discloses a process for the preparation of Azoxystrobin by reacting a cyanophenol derivative with a base in a polar organic solvent to obtain a phenolate salt followed by condensation of the aromatic substrate as shown in the scheme given below:
  • CN 102690237 discloses a process for the preparation of Azoxystrobin as shown in the scheme given below:
  • CN 102952085 discloses a process for the preparation of Azoxystrobin as shown in the scheme given below:
  • the bases used in the above method are selected from potassium carbonate, sodium carbonate, sodium hydroxide or potassium hydroxide and solvents employed are methanol, ethanol or toluene.
  • the solvents used are N-methyl pyrrolidone, N, N-dimethyl formamide, N,N-dimethyl acetamide, acetonitrile, acetone, methanol, ethanol, C to C 8 alcohols, N,N-dibutyl formamide and more preferably acetonitrile, N,N dimethyl acetamide, N, N-dimethyl formamide and the bases employed are alkali hydroxides, alkali carbonates, organic carbonates, and preferably sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, triethylamine, DBU.
  • the main objective of the present invention is to provide an improved process for the preparation of methyl (2E)-2-(2- ⁇ [6-(2-cyanophenoxy)pyrimidin-4- yl]oxy ⁇ phenyl)-3-methoxyacrylate having the following Formula I.
  • the present invention provides an improved process for the preparation of compound of Formula (I) wherein the process comprises the steps of: condensing compound of Formula II with compound of Formula (III) or a salt thereof, using tetramethyl ammonium hydroxide (TMAH) in an aromatic hydrocarbon solvent optionally in the presence of an additional base to obtain compound of Formula (I).
  • TMAH tetramethyl ammonium hydroxide
  • the present invention provides an improved process for the preparation of compound of Formula (I) i.e. methyl (2E)-2-(2- ⁇ [6-(2-cyanophenoxy) pyrimidin-4- yl]oxy ⁇ phenyl)-3-methoxyacrylate by reacting compound of Formula (II) with compound of Formula (III) using tetramethyl ammonium hydroxide (TMAH) in an aromatic hydrocarbon solvent optionally in the presence of an additional base.
  • TMAH tetramethyl ammonium hydroxide
  • reaction of compound of Formula (II) with compound of Formula (III) is effectively carried out in the presence of a tetramethylammonium hydroxide solution (TMAH) (25%) optionally in the presence of an additional base.
  • TMAH tetramethylammonium hydroxide
  • the tetra methyl ammonium hydroxide (TMAH) acts as base as well catalyst.
  • TMAH tetramethyl ammonium hydroxide
  • TMAH tetramethyl ammonium hydroxide
  • the aromatic hydrocarbon solvents employed are toluene, xylene, phenol, benzene, chlorobenzene, dichlorobenzene, cyclohexane, methylcyclohexane.
  • the reaction temperature can be varied within a relatively wide range. The temperature chosen will depend on the nature of the solvent or diluent, for example on its boiling point and/or its effectiveness for promoting the desired reaction, and on the speed at which the reaction is to be carried out. In any given solvent or diluent, the reaction will tend to progress more slowly at lower temperatures. In general, the reaction may be carried out at a temperature of from 0 to 120 °C.
  • Suitable bases are all customary inorganic and organic bases. These include, for example, alkaline earth metal and alkali metal hydroxides, acetates, carbonates, bicarbonates and hydrides such as sodium hydroxide, potassium hydroxide, sodium acetate, potassium acetate, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, calcium hydride, sodium hydride and potassium hydride, and tertiary amines.
  • Particularly suitable bases are the alkaline earth metal and alkali metal carbonates, especially potassium carbonate and sodium carbonate and. More suitably, the base employed is potassium carbonate
  • the process for the preparation of compound of Formula (I) involves dissolving compound of Formula (II) and compound of Formula (III) in toluene followed by addition of tetramethyl ammonium hydroxide solution (25%)(TMAH) at 25 °C and optionally another base.
  • TMAH tetramethyl ammonium hydroxide solution
  • the reaction mixture is heated to 105-110 °C and water is collected azeotropically. After, water was collected, the reaction was maintained at 108- 110 °C for about 8-9 hrs. After completion of the reaction, the reaction mixture is cooled and water is added to the reaction mixture. The organic layer is separated, washed with water and toluene removed under reduced pressure to get the crude compound of Formula (I).
  • the compound of Formula (I) was purified in methanol.
  • the process for obtaining azoxystrobin according to the present invention gave azoxystrobin with purity of 98%-99% and a yield of above 85 %. This is a significant improvement in comparison to the prior art methods which describe a process with a yield of 64%. Hence the process of the present invention is more economical, produces less by-products and impurities and further generates considerably less effluents as a result of the improved yield.
  • the present invention is further illustrated by the following examples which are provided merely to be exemplary of the inventions and is not intended to limit the scope of the invention. Certain modifications and equivalents will be apparent to those skilled in the art and are intended to be included within the scope of the present invention.
  • reaction mixture was heated to 105-110°C and water was removed azeotropically. After removal of water, the reaction was maintained at 108- 110 °C for about 8-9 hrs. After completion of the reaction, the reaction mass was cooled to 30-35 °C followed by addition of water. The organic and aqueous layer was separated and toluene was distilled off completely at reduced pressure below 60 °C. The obtained crude compound was recrystallized in methanol.
  • reaction was maintained at 108-110 °C for about 12-14 hrs. After completion of the reaction, the reaction mass was cooled to 30-35 °C followed by addition of water. The organic and aqueous layer was separated and toluene was distilled off completely at reduced pressure below 60 °C. The obtained crude compound was recrystallized in methanol.
  • reaction was maintained at 108-110 °C for about 24-28 hrs. After completion of the reaction, the reaction mass was cooled to 30-35 °C followed by addition of water. The organic and aqueous layer was separated and toluene was distilled off completely at reduced pressure below 60 °C. The obtained crude compound was recrystallized in methanol.
  • reaction was maintained at 108-110 °C for about 12-14 hrs. After completion of the reaction, the reaction mass was cooled to 30-35 °C followed by addition of water. The organic and aqueous layer was separated and toluene was distilled off completely at reduced pressure below 60 °C. The obtained crude compound was recrystallized in methanol.

Abstract

The present invention relates to an improved processses for synthesizing preparing substituted cyanophenoxy-pyrimidinyloxy-phenyl acrylate derivatives. The present invention specifically relates to an improved process for the preparation of methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate having the following Formula I.

Description

AN IMPROVED PROCESS FOR PREPARATION OF METHYL (2E)-2-(2- {[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-
METHOXYACRYLATE
FIELD OF THE INVENTION
The present invention relates to an improved process for preparing substituted cyanophenoxy-pyrimidinyloxy-phenyl acrylate derivatives.
The present invention specifically relates to an improved process for the preparation of methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3- methoxyacrylate having the following Formula I.
Figure imgf000002_0001
BACKGROUND OF THE INVENTION
Azoxystrobin is disclosed in US 5,395,837 and is a plant protection fungicide with protectant, curative, eradicant, translaminar and systemic properties. Azoxystrobin is a systemic fungicide commonly used in agriculture.
US 5,395,837 discloses a process for the preparation of Azoxystrobin which involves reaction between 2-cyanophenol and (E)-methyl 2-[2-(6-chlorpyridimin-4- yloxy)phenyl]-3-methoxypropenoate at temperatures ranging between 95 °C to 100 °C in dimethyl formamide in the presence of stoichiometric amounts of potassium carbonate and a catalytic amount of copper(I) chloride which is shown below :
Figure imgf000003_0001
US 8,124,761 B2 claims a process for the preparation of Azoxystrobin reacting a compound of formula II with 2-cyanophenol, or a salt thereof, in the presence of between 0.1 and 2 moles of 1, 4-diazabicyclo [2.2.2] octane, or reacting a compound of the formula III with a compound of the formula IV in the presence of between 0.1 and 2 moles of 1,4-diazabicyclo [2.2.2]octane which is shown below :
Figure imgf000003_0002
wherein W is the methyl (E)-2-(3-methoxy)acrylate group C(CO2CH3)=CHOCH3 or the methyl 2-(3,3-dimethoxy) propanoate group C(CO2CH3)CH(OCH3)2, or a mixture of the two groups.
US 8,471,013 B2 A1 discloses a process for the preparation of Azoxystrobin by reacting a cyanophenol derivative with a base in a polar organic solvent to obtain a phenolate salt followed by condensation of the aromatic substrate as shown in the scheme given below:
Figure imgf000004_0003
WO 2017/060917 A1 discloses a process for the preparation of Azoxystrobin as shown in the scheme given below:
Figure imgf000004_0004
wherein W is the methyl (E)-2-(3-methoxy) acrylate group C(CO2CH3)=CHOCH3.
CN 102690237 discloses a process for the preparation of Azoxystrobin as shown in the scheme given below:
Figure imgf000004_0001
CN 102952085 discloses a process for the preparation of Azoxystrobin as shown in the scheme given below:
Figure imgf000004_0002
The bases used in the above method are selected from potassium carbonate, sodium carbonate, sodium hydroxide or potassium hydroxide and solvents employed are methanol, ethanol or toluene.
IN 5500/CHE/2015 discloses a process for the preparation of Azoxystrobin as shown in the scheme given below:
Figure imgf000005_0001
The solvents used are N-methyl pyrrolidone, N, N-dimethyl formamide, N,N-dimethyl acetamide, acetonitrile, acetone, methanol, ethanol, C to C8 alcohols, N,N-dibutyl formamide and more preferably acetonitrile, N,N dimethyl acetamide, N, N-dimethyl formamide and the bases employed are alkali hydroxides, alkali carbonates, organic carbonates, and preferably sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, triethylamine, DBU.
The above published methods for synthesizing Azoxystrobin, however, are often complicated, such as by using a multiple step and/or time consuming synthesis process. Further, many of the above published methods do not produce high yields of the active ingredient.
Accordingly there is an ongoing and long felt need for a process for aromatic substitution reactions in the presence phenols with improved yield and selectivity.
Thus, it is the objective of the present invention to provide a process for reacting phenols under basic conditions in which the yield and selectivity is improved. OBJECTIVE OF THE INVENTION
The main objective of the present invention is to provide an improved process for the preparation of methyl (2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4- yl]oxy}phenyl)-3-methoxyacrylate having the following Formula I.
Figure imgf000006_0001
It is therefore an object of the present invention to provide a simple, economical and commercially feasible process for the synthesis methyl (2E)-2-(2-{[6-(2- cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate with a high yield and high purity.
SUMMARY OF THE INVENTION
Accordingly, the present invention provides an improved process for the preparation of compound of Formula (I)
Figure imgf000006_0002
wherein the process comprises the steps of: condensing compound of Formula II
Figure imgf000006_0003
with compound of Formula (III) or a salt thereof,
Figure imgf000007_0001
using tetramethyl ammonium hydroxide (TMAH) in an aromatic hydrocarbon solvent optionally in the presence of an additional base to obtain compound of Formula (I).
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides an improved process for the preparation of compound of Formula (I) i.e. methyl (2E)-2-(2-{[6-(2-cyanophenoxy) pyrimidin-4- yl]oxy}phenyl)-3-methoxyacrylate by reacting compound of Formula (II) with compound of Formula (III) using tetramethyl ammonium hydroxide (TMAH) in an aromatic hydrocarbon solvent optionally in the presence of an additional base.
The reaction of compound of Formula (II) with compound of Formula (III) is effectively carried out in the presence of a tetramethylammonium hydroxide solution (TMAH) (25%) optionally in the presence of an additional base. The tetra methyl ammonium hydroxide (TMAH) acts as base as well catalyst.
The tetramethyl ammonium hydroxide (TMAH) employed in the present invention is used in the range of 0.01-2 moles. Preferably, the reaction is carried out in the presence of 0.01 to 0.12 moles of tetramethyl ammonium hydroxide (TMAH).
The aromatic hydrocarbon solvents employed are toluene, xylene, phenol, benzene, chlorobenzene, dichlorobenzene, cyclohexane, methylcyclohexane. When carrying out the process of the invention, the reaction temperature can be varied within a relatively wide range. The temperature chosen will depend on the nature of the solvent or diluent, for example on its boiling point and/or its effectiveness for promoting the desired reaction, and on the speed at which the reaction is to be carried out. In any given solvent or diluent, the reaction will tend to progress more slowly at lower temperatures. In general, the reaction may be carried out at a temperature of from 0 to 120 °C.
Optionally, process of the invention is conveniently carried out in the presence or absence of base. Suitable bases are all customary inorganic and organic bases. These include, for example, alkaline earth metal and alkali metal hydroxides, acetates, carbonates, bicarbonates and hydrides such as sodium hydroxide, potassium hydroxide, sodium acetate, potassium acetate, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, calcium hydride, sodium hydride and potassium hydride, and tertiary amines. Particularly suitable bases are the alkaline earth metal and alkali metal carbonates, especially potassium carbonate and sodium carbonate and. More suitably, the base employed is potassium carbonate
The process for the preparation of compound of Formula (I) involves dissolving compound of Formula (II) and compound of Formula (III) in toluene followed by addition of tetramethyl ammonium hydroxide solution (25%)(TMAH) at 25 °C and optionally another base. The reaction mixture is heated to 105-110 °C and water is collected azeotropically. After, water was collected, the reaction was maintained at 108- 110 °C for about 8-9 hrs. After completion of the reaction, the reaction mixture is cooled and water is added to the reaction mixture. The organic layer is separated, washed with water and toluene removed under reduced pressure to get the crude compound of Formula (I). The compound of Formula (I) was purified in methanol.
The process for obtaining azoxystrobin according to the present invention gave azoxystrobin with purity of 98%-99% and a yield of above 85 %. This is a significant improvement in comparison to the prior art methods which describe a process with a yield of 64%. Hence the process of the present invention is more economical, produces less by-products and impurities and further generates considerably less effluents as a result of the improved yield. The present invention is further illustrated by the following examples which are provided merely to be exemplary of the inventions and is not intended to limit the scope of the invention. Certain modifications and equivalents will be apparent to those skilled in the art and are intended to be included within the scope of the present invention.
Example- 1:
Preparation methyl (2E)-2-(2-{[6-(2-cyanophenoxy) pyrimidin-4-yl]oxy} phenyl)-3- methoxy aery late (Azoxystrobin):
(E)-methyl 2-[2-(6-chlorpyridimin-4-yloxy) phenyl]-3-methoxy propenoate (25g, 0.078moles, l.Oeq) was dissolved in 50 ml toluene and 2-cyanophenol (10.2g, 0.086moles, l.leq) was added and the reaction mixture was stirred for 5-10 minutes. Potassium carbonate (8.6g, 0.062moles, 0.8 eq) was added and tetramethyl ammonium hydroxide solution (TMAH) (25%) (14.2g, 0.038moles, 0.5 eq) was charged into the reaction mixture at 25°C. The reaction mixture was heated to 105-110°C and water was removed azeotropically. After removal of water, the reaction was maintained at 108- 110 °C for about 8-9 hrs. After completion of the reaction, the reaction mass was cooled to 30-35 °C followed by addition of water. The organic and aqueous layer was separated and toluene was distilled off completely at reduced pressure below 60 °C. The obtained crude compound was recrystallized in methanol.
Example-2:
Preparation methyl (2E)-2-(2-{[6-(2-cyanophenoxy) pyrimidin-4-yl]oxy} phenyl)-3- methoxy aery late (Azoxystrobin):
(E)-methyl 2-[2-(6-chlorpyridimin-4-yloxy) phenyl]- 3 -methoxypropenoate (25g, 0.078moles, l.Oeq) was dissolved in 50 ml toluene and 2-cyanophenol (10.2g, 0.085moles, l.leq) was added and the reaction mixture was stirred for 5-10 minutes. Tetramethyl ammonium hydroxide solution (25%) (TMAH) (28.4g, 0.078moles, 1.0 eq) was charged into the reaction mixture at 25 °C. The reaction mixture was heated to 105- 110 °C and water was removed azeotropically. After removal of water, the reaction was maintained at 108-110 °C for about 12-14 hrs. After completion of the reaction, the reaction mass was cooled to 30-35 °C followed by addition of water. The organic and aqueous layer was separated and toluene was distilled off completely at reduced pressure below 60 °C. The obtained crude compound was recrystallized in methanol.
Example-3:
Preparation methyl (2E)-2-(2-{[6-(2-cyanophenoxy) pyrimidin-4-yl]oxy} phenyl)-3- methoxy aery late (Azoxystrobin):
(E)-methyl 2-[2-(6-chlorpyridimin-4-yloxy)phenyl]-3-methoxypropenoate (25g, 0.078moles, l.Oeq) was dissolved in 50 ml toluene and 2-cyanophenol (10.2g, 0.085moles, l.leq) was added and the reaction mixture was stirred for 5-10 minutes. Tetramethyl ammonium hydroxide solution (25%) (TMAH) (14.2g, 0.039moles, 0.5eq) was charged into the reaction mixture at 25 °C. The reaction mixture was heated to 105- 110 °C and water was removed azeotropically. After removal of water, the reaction was maintained at 108-110 °C for about 24-28 hrs. After completion of the reaction, the reaction mass was cooled to 30-35 °C followed by addition of water. The organic and aqueous layer was separated and toluene was distilled off completely at reduced pressure below 60 °C. The obtained crude compound was recrystallized in methanol.
Example-4 :
Preparation methyl (2E)-2-(2-{[6-(2-cyanophenoxy) pyrimidin-4-yl]oxy} phenyl)-3- methoxy aery late (Azoxystrobin):
(E)-methyl 2-[2-(6-chlorpyridimin-4-yloxy) phenyl]- 3 -methoxypropenoate (25g, 0.078moles, l.Oeq) was dissolved in 50 ml toluene and 2-cyanophenol (10.2g, 0.085moles, l.leq) was added and the reaction mixture was stirred for 5-10 minutes. Tetramethyl ammonium hydroxide solution (25%) (TMAH) (42.5g, 0.116moles, 1.5 eq) was charged into the reaction mixture at 25 °C. The reaction mixture was heated to 105- 110 °C and water was removed azeotropically. After removal of water, the reaction was maintained at 108-110 °C for about 12-14 hrs. After completion of the reaction, the reaction mass was cooled to 30-35 °C followed by addition of water. The organic and aqueous layer was separated and toluene was distilled off completely at reduced pressure below 60 °C. The obtained crude compound was recrystallized in methanol.

Claims

We Claim:
1. An improved process for the preparation of compound of Formula (I)
Figure imgf000012_0001
wherein the process comprises the steps of condensing the compound of Formula II,
Figure imgf000012_0002
with compound of Formula (III) or a salt thereof,
Figure imgf000012_0003
using tetramethyl ammonium hydroxide (TMAH) in an aromatic hydrocarbon solvent optionally in the presence of an additional base to obtain compound of Formula (I).
2. The process of claim 1, wherein tetramethyl ammonium hydroxide (TMAH) is in the range of 0.01 to 2 moles.
3. The process of claim 1, wherein aromatic hydrocarbon solvents is selected from toluene, xylene, phenol, benzene, chlorobenzene, dichlorobenzene, cyclohexane, methylcyclohexane, more preferably toluene.
4. The process of claim 1, wherein the additional base employed is selected from the group consisting of including alkali metal hydroxides, metal carbonates, alkali metal carbonates, and mixtures thereof.
5. The process of claim 4, wherein the alkali metal hydroxides or carbonates is sodium hydroxide, potassium hydroxide, sodium carbonate or potassium carbonate.
6. The process according to claim 1, wherein the reaction is carried out at a temperature from 0 to 120 °C.
PCT/IB2020/057273 2019-08-03 2020-07-31 An improved process for preparation of methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate WO2021024135A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR112022001999A BR112022001999A2 (en) 2019-08-03 2020-07-31 Improved process for preparing methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate
MX2022001424A MX2022001424A (en) 2019-08-03 2020-07-31 An improved process for preparation of methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-meth oxyacrylate.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201941031475 2019-08-03
IN201941031475 2019-08-03

Publications (1)

Publication Number Publication Date
WO2021024135A1 true WO2021024135A1 (en) 2021-02-11

Family

ID=74503337

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2020/057273 WO2021024135A1 (en) 2019-08-03 2020-07-31 An improved process for preparation of methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate

Country Status (3)

Country Link
BR (1) BR112022001999A2 (en)
MX (1) MX2022001424A (en)
WO (1) WO2021024135A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014183502A1 (en) * 2013-05-16 2014-11-20 北京颖泰嘉和生物科技有限公司 Preparation method of azoxystrobin
CN104672146A (en) * 2013-11-26 2015-06-03 上海泰禾化工有限公司 New high-yield preparation method of azoxystrobin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014183502A1 (en) * 2013-05-16 2014-11-20 北京颖泰嘉和生物科技有限公司 Preparation method of azoxystrobin
CN104672146A (en) * 2013-11-26 2015-06-03 上海泰禾化工有限公司 New high-yield preparation method of azoxystrobin

Also Published As

Publication number Publication date
MX2022001424A (en) 2022-04-07
BR112022001999A2 (en) 2022-03-29

Similar Documents

Publication Publication Date Title
US8664389B2 (en) Process for the preparation of lapatinib and it's pharmaceutically acceptable salts
US20110263854A1 (en) Improved Process For The Preparation Of Endothelin Receptor Antagonists
US8962832B2 (en) Process for the preparation of ambrisentan and novel intermediates thereof
US10626091B2 (en) Process for the preparation of enzalutamide
US20120245351A1 (en) Process for the preparation of lapatinib and its pharmaceutically acceptable salts
US11001574B2 (en) Process to obtain a tetrahydroisoquinoline derivative
US20130261303A1 (en) Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy-phenyl acrylate derivatives
WO2021033198A1 (en) An improved process for preparation of vilanterol or a pharmaceutically acceptable salt thereof
KR101908159B1 (en) Method for producing mandelonitrile compound
US10189793B1 (en) Method for preparing azoxystrobin
WO2021024135A1 (en) An improved process for preparation of methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate
WO2023226456A1 (en) Method for preparing azoxystrobin and intermediate thereof
US8093384B2 (en) Processes for the preparation of alfuzosin
US20130060031A1 (en) Process for the preparation of highly pure ambrisentan
CA3136883A1 (en) Process for the preparation of fungicidally active strobilurin compounds and intermediates thereof
US8563766B2 (en) Indane derivatives for use as intermediates
US10253021B2 (en) Method for producing benzoxazole compound
US20140275535A1 (en) Acid addition salts of bosentan
US20190314385A1 (en) Process for Preparation of Chlorpromazine or its Pharmaceutically Acceptable Salts
PL209540B1 (en) Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
US7223882B2 (en) Process for producing triterpene derivative
WO2012081036A2 (en) A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione)
US10807965B2 (en) Process for preparation of apalutamide
US10752586B1 (en) Process for preparation of molindone
US7365210B2 (en) Method for the production of chiral imidazolidin-2-ones

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20849337

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112022001999

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112022001999

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20220202

122 Ep: pct application non-entry in european phase

Ref document number: 20849337

Country of ref document: EP

Kind code of ref document: A1